Kwak YS - Search Results

1

Validation of cyclooxygenase-2 as a direct anti-inflammatory target of 4-O-methylhonokiol in zymosan-induced animal models.

Kim HS, Ryu HS, Kim JS, Kim YG, Lee HK, Jung JK, Kwak YS, Lee K, Seo SY, Yun J, Kang JS, Hong JT, Kim Y, Han SB. Kim HS, et al. Among authors: kwak ys. Arch Pharm Res. 2015;38(5):813-25. doi: 10.1007/s12272-014-0456-8. Epub 2014 Jul 31. Arch Pharm Res. 2015. PMID: 25074039

2

Synthesis and anti-platelet activity of obovatol derivatives.

Kwak JH, Lee S, Park ES, In JK, Song J, Kim YJ, Choi NS, Lee H, Yun YP, Hong JT, Kwak YS, Min KH, Jung JK. Kwak JH, et al. Among authors: kwak ys. Arch Pharm Res. 2011 Jul;34(7):1107-12. doi: 10.1007/s12272-011-0708-9. Epub 2011 Aug 3. Arch Pharm Res. 2011. PMID: 21811917

3

Design and synthesis of 4-O-methylhonokiol analogs as inhibitors of cyclooxygenase-2 (COX-2) and PGF₁ production.

Lee B, Kwak JH, Huang SW, Jang JY, Lim S, Kwak YS, Lee K, Kim HS, Han SB, Hong JT, Lee H, Song S, Seo SY, Jung JK. Lee B, et al. Among authors: kwak ys, kwak jh. Bioorg Med Chem. 2012 May 1;20(9):2860-8. doi: 10.1016/j.bmc.2012.03.028. Epub 2012 Mar 24. Bioorg Med Chem. 2012. PMID: 22494844

4

Novel GPR43 Agonists Exert an Anti-Inflammatory Effect in a Colitis Model.

Park BO, Kang JS, Paudel S, Park SG, Park BC, Han SB, Kwak YS, Kim JH, Kim S. Park BO, et al. Among authors: kwak ys. Biomol Ther (Seoul). 2022 Jan 1;30(1):48-54. doi: 10.4062/biomolther.2021.078. Biomol Ther (Seoul). 2022. PMID: 34168098 Free PMC article.

5

Synthesis of xanthone derivatives based on α-mangostin and their biological evaluation for anti-cancer agents.

Fei X, Jo M, Lee B, Han SB, Lee K, Jung JK, Seo SY, Kwak YS. Fei X, et al. Among authors: kwak ys. Bioorg Med Chem Lett. 2014 May 1;24(9):2062-5. doi: 10.1016/j.bmcl.2014.03.047. Epub 2014 Mar 25. Bioorg Med Chem Lett. 2014. PMID: 24717154

6

Concise Synthesis of Broussonone A.

Jo H, Choi M, Viji M, Lee YH, Kwak YS, Lee K, Choi NS, Lee YJ, Lee H, Hong JT, Lee MK, Jung JK. Jo H, et al. Among authors: kwak ys. Molecules. 2015 Sep 2;20(9):15966-75. doi: 10.3390/molecules200915966. Molecules. 2015. PMID: 26364628 Free PMC article.

7

Identification and validation of a selective small molecule inhibitor targeting the diacylglycerol acyltransferase 2 activity.

Kim MO, Lee SU, Lee HJ, Choi K, Kim H, Lee S, Oh SJ, Kim S, Kang JS, Lee HS, Kwak YS, Cho S. Kim MO, et al. Among authors: kwak ys. Biol Pharm Bull. 2013;36(7):1167-73. doi: 10.1248/bpb.b13-00152. Epub 2013 Apr 12. Biol Pharm Bull. 2013. PMID: 23585481 Free article.

8

Selective novel inverse agonists for human GPR43 augment GLP-1 secretion.

Park BO, Kim SH, Kong GY, Kim DH, Kwon MS, Lee SU, Kim MO, Cho S, Lee S, Lee HJ, Han SB, Kwak YS, Lee SB, Kim S. Park BO, et al. Among authors: kwak ys. Eur J Pharmacol. 2016 Jan 15;771:1-9. doi: 10.1016/j.ejphar.2015.12.010. Epub 2015 Dec 9. Eur J Pharmacol. 2016. PMID: 26683635

9

A novel therapeutic target, GPR43; where it stands in drug discovery.

Kim S, Kim YM, Kwak YS. Kim S, et al. Among authors: kwak ys. Arch Pharm Res. 2012 Sep;35(9):1505-9. doi: 10.1007/s12272-012-0900-6. Arch Pharm Res. 2012. PMID: 23054706 Review.

10

An efficient synthetic protocol for amide derivatives of Boc-2-aminoisobutyrate.

Jo M, Won SW, Lee DG, Jung JK, Kim S, Kwak YS. Jo M, et al. Among authors: kwak ys. Arch Pharm Res. 2018 Mar;41(3):259-264. doi: 10.1007/s12272-018-1009-3. Epub 2018 Feb 24. Arch Pharm Res. 2018. PMID: 29478110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page